Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days

Elise A Verhagen1, Elisabeth M W Kooi, Paul P van den Berg

  • 1Division of Neonatology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. e.a.verhagen@umcg.nl

Insights

Maternal use of labetalol and magnesium sulfate during pregnancy may affect cerebral oxygen extraction in preterm infants shortly after birth. Nifedipine did not show a similar effect on infant cerebral oxygenation.

Area of Science:

  • Neonatal physiology
  • Pharmacology
  • Perinatal medicine

Background:

  • Preterm infants are at risk for altered cerebral oxygenation.
  • Maternal antihypertensive medications are commonly used during pregnancy.
  • The impact of these medications on neonatal cerebral oxygenation requires further investigation.

Purpose of the Study:

  • To investigate the influence of maternal antihypertensive drugs on cerebral oxygenation in preterm infants.
  • To assess regional cerebral oxygen saturation (rcSO2) and fractional tissue oxygen extraction (FTOE) in neonates exposed to specific maternal medications.

Main Methods:

  • A cohort of 49 preterm infants (median gestational age 30.3 weeks) was studied.
  • Regional cerebral oxygen saturation (rcSO2) was measured using near-infrared spectroscopy on postnatal days 1-5.
  • Fractional tissue oxygen extraction (FTOE) was calculated using rcSO2 and SpO2.

Main Results:

  • Infants born to mothers treated with labetalol and/or MgSO4 showed decreased FTOE on day 1.
  • Maternal nifedipine treatment did not significantly alter infant FTOE.
  • Multivariate analysis confirmed these findings in relation to maternal medication exposure.

Conclusions:

  • Maternal treatment with labetalol and/or MgSO4 may positively influence cerebral oxygen extraction in preterm neonates.
  • Nifedipine did not demonstrate a similar effect on early neonatal cerebral oxygenation.
  • These findings suggest a potential short-term benefit of certain antihypertensives on neonatal brain oxygenation.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...